Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Virology Specimen Collection Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
The global virology specimen collection market demonstrates significant industrial growth and emerging technological trends, according to an insightful market research report now available on our website. This comprehensive study provides an in-depth analysis of market dynamics across various regions, with a spotlight on the Asia-Pacific's rapid growth trajectory.
In the past few years, the virology specimen collection industry has seen substantial expansion, and the trend is expected to continue. In the recent report, the market is noted to have achieved a robust growth of 6.1% CAGR, surging from a valuation of $6.18 billion in 2023 to an estimated $6.56 billion in 2024.
The report elucidates on key factors propelling this growth, including an increase in global health crises, advances in technology, and a rising emphasis on remote testing and home-based specimen collection methods. Notably, the Asia-Pacific region is poised for the fastest growth within the forecast period, underpinned by health infrastructure improvements and heightened awareness of viral infections' importance.
Virology Specimen Collection Market: A Closer Look at Technological Innovations
Automated sample isolation and on-the-spot amplification systems are revolutionizing virology specimen collection by increasing the efficacy and speed of virus detection.
Self-collection blood kits are enhancing flexibility and inclusivity in clinical trials and research, enabling participation from remote locations. A Finnish health tech firm's 2023 launch of a remote blood collection kit exemplifies this innovation.
The report also accentuates the strategic business moves within the industry, such as recent acquisitions that consolidate market presence and expand product portfolios into new segments.
Key Findings and Anticipated Market Behavior
The market is projected to reach an impressive $8.23 billion by 2028 at a CAGR of 5.8%.
Demand for virology specimen collection products is increasing in line with rising blood donation activities and the prevalence of viral diseases like HIV/AIDS and influenza.
Majestic strides in technology and product innovation by predominant industry players are set to redefine market dynamics.
Significant growth and opportunities are identified across North America and the Asia-Pacific regions, driven by strategic developments and expanded global reach.
The findings are based on an exhaustive examination of the industry, including detailed segmentation, regional analysis, and insight into the competitive landscape. The report concludes that the virology specimen collection market remains on an upward trajectory, fueled by technological advancements, heightened disease awareness, and strategic industry alliances.
A selection of companies mentioned in this report includes
Puritan Medical Products Co. LLC
Becton Dickinson and Company
Thermo Fisher Scientific Inc.
Trinity Biotech plc
Titan Biotech Ltd.
Copan Italia S.p.A.
Laboratory Corporation of America Holdings
Copan Diagnostics Inc.
F. Hoffmann-La Roche Ltd
Meridian Bioscience Inc.
Bio-Rad Laboratories Inc.
GenMark Diagnostics Inc.
BioFire Diagnostics LLC
Randox Laboratories Ltd.
Savyon Diagnostics Ltd.
SolGent Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/ocenxe
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900